Clinical Trial Update: Study That Tests AD109 in Patients Taking GLP-1 Drugs [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating AD109 in patients taking GLP-1 medications for obstructive sleep apnea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• AD109

Snippet

Sponsor: Apnimed | Conditions: OSA | Phase 2 | Status: COMPLETED